Search research articles
Contact Us
Filters
Showing results (251-260 of 276) with videos related to
Page
of 28
Sort By:
European Journal of Cancer (Oxford, England : 1990)
|
April 2, 2022
MAPKinase inhibition after failure of immune checkpoint blockade in patients with advanced melanoma - An evaluation of the multicenter prospective skin cancer registry ADOREG
Sophia Kreft, Valerie Glutsch, Anne Zaremba, et al.
Journal for Immunotherapy of Cancer
|
May 7, 2020
Impact of a preceding radiotherapy on the outcome of immune checkpoint inhibition in metastatic melanoma: a multicenter retrospective cohort study of the DeCOG
Sarah Knispel, Andreas Stang, Lisa Zimmer, et al.
European Journal of Cancer (Oxford, England : 1990)
|
June 8, 2021
Clinical characteristics and therapy response in unresectable melanoma patients stage IIIB-IIID with in-transit and satellite metastases
Anne Zaremba, Manuel Philip, Jessica C Hassel, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
June 16, 2022
Prognosis of Patients With Primary Melanoma Stage I and II According to American Joint Committee on Cancer Version 8 Validated in Two Independent Cohorts: Implications for Adjuvant Treatment
Claus Garbe, Ulrike Keim, Teresa Amaral, et al.
Cancers
|
April 12, 2022
Real-World Therapy with Pembrolizumab: Outcomes and Surrogate Endpoints for Predicting Survival in Advanced Melanoma Patients in Germany
Peter Mohr, Emilie Scherrer, Chalid Assaf, et al.
European Journal of Cancer (Oxford, England : 1990)
|
December 25, 2025
Enhanced overall and progression-free survival in advanced melanoma patients undergoing targeted therapy alongside antithrombotic treatment - Insights from a multicenter study involving 1296 patients from the prospective skin cancer registry ADOReg
Noah Zimmermann, Julian Kött, Tim Zell, et al.
Frontiers in Immunology
|
March 11, 2025
Treatment at the end of life in patients with advanced melanoma. A multicenter DeCOG study of 1067 patients from the prospective skin cancer registry ADOReg
Andrea Forschner, Katharina C Kähler, Martin Gschnell, et al.
Nature Cancer
|
July 31, 2023
Interleukin 17 signaling supports clinical benefit of dual CTLA-4 and PD-1 checkpoint inhibition in melanoma
Renáta Váraljai, Lisa Zimmer, Yahya Al-Matary, et al.
Cancers
|
February 15, 2022
Immune Checkpoint Blockade for Metastatic Uveal Melanoma: Re-Induction following Resistance or Toxicity
Elias A T Koch, Anne Petzold, Anja Wessely, et al.
Nature Cancer
|
August 14, 2023
Author Correction: Interleukin 17 signaling supports clinical benefit of dual CTLA-4 and PD-1 checkpoint inhibition in melanoma
Renáta Váraljai, Lisa Zimmer, Yahya Al-Matary, et al.
Page
of 28
Search research articles
Search
Showing results (251-260 of 276) with videos related to
Sort By:
Page
of 28
European Journal of Cancer (Oxford, England : 1990)
|
April 2, 2022
MAPKinase inhibition after failure of immune checkpoint blockade in patients with advanced melanoma - An evaluation of the multicenter prospective skin cancer registry ADOREG
Sophia Kreft, Valerie Glutsch, Anne Zaremba, et al.
Journal for Immunotherapy of Cancer
|
May 7, 2020
Impact of a preceding radiotherapy on the outcome of immune checkpoint inhibition in metastatic melanoma: a multicenter retrospective cohort study of the DeCOG
Sarah Knispel, Andreas Stang, Lisa Zimmer, et al.
European Journal of Cancer (Oxford, England : 1990)
|
June 8, 2021
Clinical characteristics and therapy response in unresectable melanoma patients stage IIIB-IIID with in-transit and satellite metastases
Anne Zaremba, Manuel Philip, Jessica C Hassel, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
June 16, 2022
Prognosis of Patients With Primary Melanoma Stage I and II According to American Joint Committee on Cancer Version 8 Validated in Two Independent Cohorts: Implications for Adjuvant Treatment
Claus Garbe, Ulrike Keim, Teresa Amaral, et al.
Cancers
|
April 12, 2022
Real-World Therapy with Pembrolizumab: Outcomes and Surrogate Endpoints for Predicting Survival in Advanced Melanoma Patients in Germany
Peter Mohr, Emilie Scherrer, Chalid Assaf, et al.
European Journal of Cancer (Oxford, England : 1990)
|
December 25, 2025
Enhanced overall and progression-free survival in advanced melanoma patients undergoing targeted therapy alongside antithrombotic treatment - Insights from a multicenter study involving 1296 patients from the prospective skin cancer registry ADOReg
Noah Zimmermann, Julian Kött, Tim Zell, et al.
Frontiers in Immunology
|
March 11, 2025
Treatment at the end of life in patients with advanced melanoma. A multicenter DeCOG study of 1067 patients from the prospective skin cancer registry ADOReg
Andrea Forschner, Katharina C Kähler, Martin Gschnell, et al.
Nature Cancer
|
July 31, 2023
Interleukin 17 signaling supports clinical benefit of dual CTLA-4 and PD-1 checkpoint inhibition in melanoma
Renáta Váraljai, Lisa Zimmer, Yahya Al-Matary, et al.
Cancers
|
February 15, 2022
Immune Checkpoint Blockade for Metastatic Uveal Melanoma: Re-Induction following Resistance or Toxicity
Elias A T Koch, Anne Petzold, Anja Wessely, et al.
Nature Cancer
|
August 14, 2023
Author Correction: Interleukin 17 signaling supports clinical benefit of dual CTLA-4 and PD-1 checkpoint inhibition in melanoma
Renáta Váraljai, Lisa Zimmer, Yahya Al-Matary, et al.
Page
of 28